Characterization of Use of Attention-Deficit/Hyperactivity Disorder (ADHD) Medications or Opioid Analgesics: A Descriptive Analysis

In these reports, we assessed the use of attention-deficit/hyperactivity disorder (ADHD) medications or opioid analgesics within pre- and post-COVID-19 pandemic time periods among pre-specified age groups in the Sentinel Distributed Database (SDD). We separately identified cohorts of individuals five years of age and older who initiated ADHD stimulant medications, ADHD non-stimulant medications, or Schedule II (C-II) opioid analgesics and described demographics and clinical characteristics for each age-based drug class cohort.

The overall study period includes data from January 1, 2017 to March 31, 2023. We distributed this request to eight Sentinel Data Partners on May 10, 2024.

This analysis contains four reports: 

• Report 1: The report includes the overall query period: January 1, 2017 to March 31, 2023.
• Report 2: This reports includes the pre-pandemic query period: April 1, 2018 to March 31, 2020.
• Report 3: This report includes the pandemic query period: April 1, 2020 to March 31, 2022.
• Report 4: This report includes the latest available data query period: April 1, 2022 to March 31, 2023.